17:02:03United States

Immatics N.V. (IMTX)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
-196,447,000 -1390.9%
Operating income
-182,016,000
Earnings per share
-1.61 -1250%
R&D expense
183,832,000

Growth and profitability

Return on equity
-40.58
Return on assets
-34.93

Balance sheet

Total assets
562,337,000
Shareholders' equity
484,099,000
Cash and equivalents
345,918,000
Current ratio
11.72

Cash flow and ratios

Operating cash flow
-176,626,000
Free cash flow
-183,184,000

Shareholder returns

Shares outstanding
134,071,432
Book value per share
3.61
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Tubingen, 2M
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Biological Products, (no Diagnostic Substances)

Fiscal year end: · Source: SEC EDGAR

Immatics N.V. trades on NASDAQ under the ticker symbol IMTX. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis